Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.

Hepatology (Baltimore, Md.) - 1 Aug 2004

Dikopoulos Nektarios, Riedl Petra, Schirmbeck Reinhold, Reimann Jörg

Abstract excerpt

Vaccines for the prophylactic and/or therapeutic immunization against hepatotropic pathogens (e.g., hepatitis B and hepatitis C virus) should establish long-lasting, specific antiviral effector/memory CD8+ T cell immunity in the liver. We describe a novel peptide-based vaccine in which antigenic major histocompatibility complex Class I-binding peptides are fused to a cationic (e.g., human immunodeficiency virus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cations
Share to Immune Tolerance
Share to Immunity, Cellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunization, Secondary

Share to Immunologic Memory

Share to Receptors, Interleukin-2

Share to Vaccines, Subunit

Share to Viral Hepatitis Vaccines

Source

Identifiers

PMID: 15368434
DOI: 10.1002/hep.20330

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.PMID 15368434Read ↗

Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.Semantic proximity Read ↗

Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naïve CD8+ T cells in the mouse.Semantic proximity Read ↗

In Vivo Clearance of Hepatitis C Virus Nonstructural 3/4A–Expressing Hepatocytes by DNA Vaccine–Primed Cytotoxic T LymphocytesSemantic proximity Read ↗

Tissue-Resident Memory T Cells in the Liver-Unique Characteristics of Local Specialists.Semantic proximity Read ↗

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.Semantic proximity Read ↗

A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.Semantic proximity Read ↗

Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant ChainSemantic proximity Read ↗

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.Semantic proximity Read ↗

Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinomaSemantic proximity Read ↗

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.Semantic proximity Read ↗

Accumulation of PD-1+ TIGIT+ T cells in the liver after local antigen reactivity and during autoimmune hepatitisSemantic proximity Read ↗

Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.